In addition to gastrointestinal diseases, the Alpha10 is used to diagnose pancreatic, esophageal, rectal, gastric and lung cancers, and other benign tumors.  According to Ruth Hopkins, RN, Nurse Manager, “The Alpha10 is used daily by specialists at NYHQ to access lesions and tumors in the body without surgery. This improves patient care, and facilitates diagnosis and treatment for patients in the Queens Community.”

Assemblywoman Carrozza said: “It’s great that we have been able to work together to secure the vital funds necessary for New York Hospital Queens to purchase state-of-the-art diagnostic technology to assist patients suffering from gastrointestinal diseases.”

Stephen S. Mills, President and Chief Executive Officer of NYHQ, said “This has been one of the most challenging times in health care and I am grateful that we have advocates like Assemblywoman Ann-Margaret Carrozza, who understands that the people of Queens deserves the highest quality care right here.”